Attached files
file | filename |
---|---|
10-K - FORM 10-K - ATHERSYS, INC / NEW | c97513e10vk.htm |
EX-23 - EXHIBIT 23 - ATHERSYS, INC / NEW | c97513exv23.htm |
EX-24.2 - EXHIBIT 24.2 - ATHERSYS, INC / NEW | c97513exv24w2.htm |
EX-31.1 - EXHIBIT 31.1 - ATHERSYS, INC / NEW | c97513exv31w1.htm |
EX-32.1 - EXHIBIT 32.1 - ATHERSYS, INC / NEW | c97513exv32w1.htm |
EX-24.1 - EXHIBIT 24.1 - ATHERSYS, INC / NEW | c97513exv24w1.htm |
EX-31.2 - EXHIBIT 31.2 - ATHERSYS, INC / NEW | c97513exv31w2.htm |
EX-10.45 - EXHIBIT 10.45 - ATHERSYS, INC / NEW | c97513exv10w45.htm |
EX-10.43 - EXHIBIT 10.43 - ATHERSYS, INC / NEW | c97513exv10w43.htm |
EX-10.42 - EXHIBIT 10.42 - ATHERSYS, INC / NEW | c97513exv10w42.htm |
EXHIBIT 21
SUBSIDIARIES OF ATHERSYS, INC.
Name of Subsidiary | Jurisdiction | |
ABT Holding Company (formerly Athersys, Inc.) |
Delaware | |
Advanced Biotherapeutics, Inc. |
Delaware | |
Athersys Limited |
United Kingdom | |
ReGenesys LLC |
Delaware | |
ReGenesys BVBA |
Belgium | |
Oculus Pharmaceuticals, Inc. (50% ownership) |
Delaware |